We discovered that thiopurine drugs have potent antiviral activities against respiratory viruses including influenza viruses, SARS-CoV-2 and “common cold” coronaviruses. Inhibition of human GTPase enzymes is central to the antiviral mechanism of action of these thiopurines, but the precise target enzymes remain unknown. The primary goal of the current proposal is to work with Applied […]
Read More